• Login
    View Item 
    •   DORA Home
    • Faculty of Health and Life Sciences
    • School of Allied Health Sciences
    • View Item
    •   DORA Home
    • Faculty of Health and Life Sciences
    • School of Allied Health Sciences
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Engineering novel complement activity into a pulmonary-surfactant protein

    Thumbnail
    Date
    2010-04
    Author
    Venkatraman Girija, U.;
    Furze, C.;
    Toth, J.;
    Schwaeble, W. J.;
    Mitchell, D. A.;
    Keeble, A. H.;
    Wallis, R.
    Metadata
    Show attachments and full item record
    Abstract
    Complement neutralizes invading pathogens, stimulates inflammatory and adaptive immune responses, and targets non- or altered-self structures for clearance. In the classical and lectin activation pathways, it is initiated when complexes composed of separate recognition and activation subcomponents bind to a pathogen surface. Despite its apparent complexity, recognition-mediated activation has evolved independently in three separate protein families, C1q, mannose-binding lectins (MBLs), and serum ficolins. Although unrelated, all have bouquet-like architectures and associate with complement-specific serine proteases: MBLs and ficolins with MBL-associated serine protease-2 (MASP-2) and C1q with C1r and C1s. To examine the structural requirements for complement activation, we have created a number of novel recombinant rat MBLs in which the position and orientation of the MASP-binding sites have been changed. We have also engineered MASP binding into a pulmonary surfactant protein (SP-A), which has the same domain structure and architecture as MBL but lacks any intrinsic complement activity. The data reveal that complement activity is remarkably tolerant to changes in the size and orientation of the collagenous stalks of MBL, implying considerable rotational and conformational flexibility in unbound MBL. Furthermore, novel complement activity is introduced concurrently with MASP binding in SP-A but is uncontrolled and occurs even in the absence of a carbohydrate target. Thus, the active rather than the zymogen state is default in lectin.MASP complexes and must be inhibited through additional regions in circulating MBLs until triggered by pathogen recognition.
    Description
    Citation : Venkatraman Girija, U., Furze, C., Toth, J., Schwaeble, W.J., Mitchell, D.A., Keeble, A.H. and Wallis, R. (2010) Engineering novel complement activity into a pulmonary-surfactant protein. The Journal of Biological Chemistry, 285 (14), pp. 10546-10552
    URI
    http://hdl.handle.net/2086/11000
    DOI
    http://dx.doi.org/10.1074/jbc.M109.097493
    Research Group : Infectious Disease Research Group
    Research Institute : Institute for Allied Health Sciences Research
    Peer Reviewed : Yes
    Collections
    • School of Allied Health Sciences [1420]

    Submission Guide | Reporting Guide | Reporting Tool | DMU Open Access Libguide | Take Down Policy | Connect with DORA
    DMU LIbrary
     

     

    Browse

    All of DORACommunities & CollectionsAuthorsTitlesSubjects/KeywordsResearch InstituteBy Publication DateBy Submission DateThis CollectionAuthorsTitlesSubjects/KeywordsResearch InstituteBy Publication DateBy Submission Date

    My Account

    Login

    Submission Guide | Reporting Guide | Reporting Tool | DMU Open Access Libguide | Take Down Policy | Connect with DORA
    DMU LIbrary